A phase I/II study of belinostat (PXD101) in patients with unresectable hepatocellular carcinoma

15081 Background: Hepatocellular carcinoma (HCC) is a common cause of cancer morbidity and mortality. It is a highly aggressive tumor with 90% presenting with unresectable disease, resulting in a m...